Inactief instrument

Andere talen Wintac Limited

Aandelen

524758

INE812C01016

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Somerset Therapeutics Limited Reports Earnings Results for the Full Year Ended March 31, 2023	10-08-23
Wintac Limited Reports Earnings Results for the Full Year Ended March 31, 2022	11-08-22
Wintac Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020	12-11-20
Wintac : Clearent acquires Wintac to expand field-service management software solutions	24-09-20
Wintac Limited Reports Earnings Results for the First Quarter Ended June 30, 2020	07-08-20
Wintac Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2020	22-06-20
Wintac Limited Reports Earnings Results for the Third Quarter Ended December 31, 2019	04-02-20
Wintac Limited Appoints S. Nanthitha as Additional Director	04-02-20
Wintac Limited Announces Resignation of Ms. K. M. Ganga as Independent Director	27-01-20
Wintac Limited Reports Earnings Results for the Second Quarter Ended September 30, 2019	13-11-19
Wintac Limited Reports Earnings Results for the First Quarter Ended June 30, 2019	12-08-19
Wintac Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2019	23-05-19
Par Formulations Pvt Ltd cancelled the acquisition of Pharmaceutical Business from Wintac Limited.	27-02-19
Wintac Ltd. Reports Earnings Results for the Third Quarter Ended December 31, 2018	11-02-19
Wintac Ltd Announces Unaudited Standalone Financial Results for the Second Quarter and Six Months Ended September 30, 2018	12-11-18
Wintac Ltd. Reports Unaudited Earnings Results for the First Quarter Ended June 30, 2018	07-08-18
Wintac Limited Announces Resignation of B. R. Arun Eashwar as Independent Director	29-05-18
Wintac Limited Announces Audited Earnings Results for the Fourth Quarter and Year Ended March 31, 2018	23-05-18
Wintac Limited Appoints R.A.Thirumoorti as Additional Director	23-05-18
Par Formulations Pvt Ltd agreed to acquire Pharmaceutical Business from Wintac Limited for $15.3 million.	26-04-18

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Wintac Limited

Aandelen

524758

INE812C01016

Andere talen

Filters